Potential of Flavonoid Compounds from Rhodomyrtus tomentosa as Anticholesterol: An In Silico Study
Journal of Tropical Biodiversity · 2024
DOI: 10.59689/bio.v4i3.232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tropical Biodiversity, 2024. Verfasst von Lamtiur Lumbantoruan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Indonesia's biodiversity ranks second largest in the world. This vast potential, if managed well, can be utilized as raw materials for medicines. Currently, 96% of drug raw materials in Indonesia are still imported, making medicines expensive. Therefore, efforts are needed to achieve self-sufficiency in drug raw materials, including researching Indonesian plants with potential as hypercholesterolemia drugs to be used as native raw materials. This study aims to determine the potential of flavonoid compounds in Rhodomyrtus tomentosa fruit as an alternative hypercholesterolemia drug. Six flavonoids were identified: myricetin, quercetin, quercetin 7,4'-diglucoside, dihydromyricetin, kaempferol, and vitexin in R. tomentosa (Karamunting) fruit. The method used was an in silico study. In silico studies are used to screen compounds based on their mechanism of action against target proteins. In this study, myricetin, quercetin, dihydromyricetin, kaempferol, quercetin 7,4'-diglucoside, and vitexin were subjected to molecular docking using Autodock Vina software to determine the affinity and interaction of these six compounds with the HMG-CoA reductase enzyme, which acts as an intermediary in the mevalonate pathway for cholesterol metabolism. Simvastatin, a drug used for hypercholesterolemia treatment, was used as a comparison. The molecular docking results showed that the binding energy values for myricetin, quercetin, dihydromyricetin, kaempferol, quercetin 7,4'-diglucoside, and vitexin were -10.0, -9.4, -9.6, -9.2, -11.4, and -9.9 kcal/mol, respectively. These six flavonoid derivatives from Karamunting fruit have better inhibition scores compared to simvastatin, indicating that these flavonoid derivatives can inhibit cholesterol biosynthesis better than simvastatin and have potential as anticholesterol drugs.
Zitieren
APA
Lumbantoruan, L., Sinaga, E., Simanjuntak, K., Nurbaya, S., & Prasasty, V. D. (2024). Potential of Flavonoid Compounds from Rhodomyrtus tomentosa as Anticholesterol: An In Silico Study. Journal of Tropical Biodiversity. https://doi.org/10.59689/bio.v4i3.232
Vancouver
Lumbantoruan L, Sinaga E, Simanjuntak K, Nurbaya S, Prasasty VD. Potential of Flavonoid Compounds from Rhodomyrtus tomentosa as Anticholesterol: An In Silico Study. Journal of Tropical Biodiversity. 2024. doi:10.59689/bio.v4i3.232
BibTeX
@article{Lumbantoruan2024,
author = {Lumbantoruan, Lamtiur and Sinaga, Ernawati and Simanjuntak, Kristina and Nurbaya, Siti and Prasasty, Vivitri Dewi},
title = {Potential of Flavonoid Compounds from Rhodomyrtus tomentosa as Anticholesterol: An In Silico Study},
journal = {Journal of Tropical Biodiversity},
year = {2024},
doi = {10.59689/bio.v4i3.232}
}
EUVIMED